Roger M Leblanc Selected Research

Roger M Leblanc Research Topics

Disease

19	Neoplasms (Cancer) 01/2024 - 10/2003
8	Alzheimer Disease (Alzheimer's Disease) 07/2022 - 09/2004
5	Glioblastoma (Glioblastoma Multiforme) 11/2023 - 03/2019
4	Brain Neoplasms (Brain Tumor) 05/2023 - 09/2016
3	Neuroblastoma 01/2023 - 01/2022
3	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 01/2016
3	Amyloid Plaque 11/2012 - 12/2009
2	Parkinson Disease (Parkinson's Disease) 11/2019 - 09/2010
2	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2014 - 08/2010
1	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 05/2023
1	Congenital Abnormalities (Deformity) 12/2022
1	Keratitis 01/2022
1	Liver Neoplasms (Liver Cancer) 12/2021
1	Waterborne Diseases 10/2021
1	Nervous System Diseases (Neurological Disorders) 06/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Infections 01/2021
1	Central Nervous System Diseases (CNS Diseases) 01/2021
1	Dementia (Dementias) 11/2019
1	Mycoses (Diseases, Fungus) 01/2019
1	Leukemia 04/2014
1	Sarcoidosis (Schaumann Disease) 04/2014
1	Type 2 Diabetes Mellitus (MODY) 12/2012
1	Amyloidosis 08/2010
1	Myocardial Infarction 03/2010
1	Neoplasm Metastasis (Metastasis) 10/2003
1	Arthritis (Polyarthritis) 10/2003

Drug/Important Bio-Agent (IBA)

13	CarbonIBA 01/2024 - 09/2016
6	Proteins (Proteins, Gene)FDA Link 11/2019 - 08/2010
5	LigandsIBA 05/2023 - 02/2018
5	Peptides (Polypeptides)IBA 09/2017 - 09/2004
4	Amyloid (Amyloid Fibrils)IBA 11/2019 - 01/2011
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 03/2010
3	Transferrin (beta 2 Transferrin)IBA 01/2022 - 09/2016
3	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2021 - 09/2016
3	alpha-L-Fucosidase (Fucosidase)IBA 01/2017 - 01/2016
3	Amyloid beta-PeptidesIBA 12/2012 - 09/2004
2	Temozolomide (Temodar)FDA LinkGeneric 01/2024 - 03/2019
2	DNA (Deoxyribonucleic Acid)IBA 05/2023 - 01/2022
2	cyanogenIBA 07/2022 - 04/2020
2	tau Proteins (tau Protein)IBA 07/2022 - 11/2019
2	Rose BengalIBA 01/2022 - 01/2021
2	LipidsIBA 12/2021 - 10/2011
2	EnzymesIBA 10/2021 - 01/2016
2	Transferrin Receptors (Transferrin Receptor)IBA 01/2021 - 09/2016
2	Islet Amyloid PolypeptideIBA 12/2012 - 11/2012
1	chlorophyllin (copper chlorophyll)IBA 01/2024
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2024
1	MicellesIBA 05/2023
1	Liposomes (Liposome)IBA 05/2023
1	Dendrimers (Dendrons)IBA 05/2023
1	Ophthalmic Solutions (Eye Drops)IBA 05/2023
1	CytosineIBA 12/2022
1	ChalconesIBA 07/2022
1	Glutamine (L-Glutamine)FDA Link 07/2022
1	KetonesIBA 07/2022
1	Memantine (Namenda)FDA Link 07/2022
1	Riboflavin (Vitamin B2)FDA LinkGeneric 01/2022
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 01/2022
1	Eflornithine (Ornidyl)FDA Link 01/2022
1	Polysaccharides (Glycans)IBA 12/2021
1	Water PollutantsIBA 10/2021
1	GalactosidasesIBA 10/2021
1	Singlet OxygenIBA 01/2021
1	Gemcitabine FDA Link 04/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2019
1	AcetylcholinesteraseIBA 11/2019
1	Epirubicin (Ellence)FDA LinkGeneric 03/2019
1	Nanoparticle Drug Delivery SystemIBA 03/2019
1	Chalcone (Benzalacetophenone)IBA 03/2019
1	CurcuminIBA 03/2019
1	FumonisinsIBA 01/2019
1	fumonisin B1IBA 01/2019
1	Dihydrotachysterol (AT 10)IBA 09/2016
1	IsoenzymesIBA 01/2016
1	GlypicansIBA 01/2016
1	Fetal Proteins (Fetoprotein)IBA 01/2016
1	squamous cell carcinoma-related antigenIBA 01/2016
1	TransferasesIBA 01/2016
1	Blood Proteins (Serum Proteins)IBA 01/2016
1	Muramidase (Lysozyme)IBA 04/2014
1	Human Serum Albumin FDA LinkGeneric 12/2012
1	Tryptophan (L-Tryptophan)FDA Link 12/2012
1	Tyrosine (L-Tyrosine)FDA Link 12/2012
1	Amino Acids FDA Link 12/2012
1	CholesterolIBA 10/2011
1	CotinineIBA 01/2011
1	Intrinsically Disordered ProteinsIBA 09/2010
1	alpha-SynucleinIBA 09/2010
1	Troponin IIBA 03/2010
1	CollagenIBA 10/2003

Therapy/Procedure

13	Therapeutics 01/2024 - 01/2011
4	Drug Therapy (Chemotherapy) 01/2024 - 01/2019
2	Quantum Dots (Quantum Dot) 05/2023 - 02/2018
1	Lenses 05/2023
1	Contact Lenses 05/2023
1	Radiotherapy 01/2019